Diclegis Tablet, Delayed Release
Product Images NDC 55494-100

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diclegis (NDC 55494-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Duchesnay Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label-outside Front Cover With Imprint Area For Lot & Expiry (Bottle Label 1)

Diclegis® is a drug that comes in delayed-release tablets of 10mg/t0mg of Dowfamine Succineteand Pyridoxine Hydrochloride. It is recommended to swallow the tablets whole, without crushing, chewing, or splitting them. Each tablet contains 10mg of Doglamine suceinat and Pyridoine hycrochiords. The standard dosage is two tablets daily, but it can be increased up to four tablets if symptoms are not adequately controlled. The tablets must be stored in their original container or the corresponding light-resistant container and protected from light. Diclegis® is manufactured in Canada and distributed by Duchosnay USA, Inc.*

FDA Label Image

Bottle Label – Inside Cover (Bottle Label Inside)

Store s20°C 025°C (68F 0 NDC 55494-100-10. Dicklegis® tablets are a combination of two medications, Doxylamine Succinate and Pyridoxine Hydrochloride. They are used to treat nausea and vomiting. Each prescription contains 100 delayed-release tablets. The tablets must not be crushed, chewed, or split. Duchesnay USA Inc. located in Bryn Mawr, PA distributes it. For more information about the product, contact Progan at 1-800-470-6128.*

FDA Label Image

Structure-1 (Structure 1)

FDA Label Image

Structure-2 (Structure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.